Risk of progression following a negative biopsy in prostate cancer active surveillance

被引：0
|
作者：
Kerri Beckmann
Aida Santaolalla
Mikio Sugimoto
Peter Carroll
Jose Rubio
Arnauld Villers
Anders Bjartell
Todd Morgan
Prokar Dasgupta
Mieke Van Hemelrijck
Oussama Elhage
机构：
[1] University of South Australia,Cancer Epidemiology and Population Health Research Group
[2] Kings College London,Translational Oncology and Urology Research
[3] Kagawa University,Faculty of Medicine
[4] University of California San Francisco,Department of Urology, UCSF—Helen Diller Comprehensive Cancer Centre
[5] Instituto Valenciano de Oncologia,Department of Urology
[6] Lille University Hospital Center,Immunology and Microbial Sciences
[7] Skane University Hospital,undefined
[8] University of Michigan and Michigan Urological Surgery Improvement Collaborative,undefined
[9] Guy’s and St Thomas’ NHS Foundation Trust,undefined
[10] King’s College London,undefined
来源：
Prostate Cancer and Prostatic Diseases | 2023年 / 26卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：403 / 409
页数：6
相关论文
共 50 条
  • [21] Implications of a Negative Confirmatory Biopsy Among Men on Active Surveillance for Prostate Cancer Along with PTEN/ERG as a Predictor of Pathologic Progression
    Prasad, Anil
    Lin, Kirk
    Prasad, Ashish
    Bartlett, Zane
    Belkoff, Kenneth
    Page, Jay
    Levine, Michael
    Shah, Rajal
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 597 - 597
  • [22] Is BMI a risk factor for active surveillance progression in patients with prostate cancer diagnosed by MRI-Trus fusion biopsy?
    Rayn, Kareem
    Gold, Samuel
    Hale, Graham R.
    Baiocco, Joey
    Bloom, Jonathan
    Valera, Vladimir
    Wood, Brad J.
    Turkbey, Baris
    Pinto, Peter A.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [23] MRI-TRUS GUIDED FUSION BIOPSY TO DETECT PROGRESSION ON ACTIVE SURVEILLANCE FOR LOW AND INTERMEDIATE RISK PROSTATE CANCER
    Frye, Thomas P.
    Shakir, Nabeel
    Abboud, Steven
    George, Arvin K.
    Merino, Maria
    Choyke, Peter
    Turkbey, Baris
    Wood, Bradford
    Pinto, Peter A.
    JOURNAL OF UROLOGY, 2015, 193 (04): : E654 - E654
  • [24] Prediagnostic prostate-specific antigen kinetics and the risk of biopsy progression in active surveillance patients
    Iremashvili, Viacheslav
    Barney, Shane L.
    Manoharan, Murugesan
    Kava, Bruce R.
    Parekh, Dipen J.
    Punnen, Sanoj
    INTERNATIONAL JOURNAL OF UROLOGY, 2016, 23 (04) : 313 - 317
  • [25] CANCER OF THE PROSTATE RISK ASSESSMENT SCORE FOLLOWING BIOPSY GLEASON UPGRADE DURING PROSTATE CANCER ACTIVE SURVEILLANCE IS ASSOCIATED WITH ADVERSE PATHOLOGY AT PROSTATECTOMY
    Leapman, Michael
    Ameli, Niloufar
    Chu, Carissa
    Hussein, Ahmed
    Welty, Christopher
    Cooperberg, Matthew
    Carroll, Peter
    JOURNAL OF UROLOGY, 2015, 193 (04): : E513 - E513
  • [26] Bilateral disease and risk of prostate cancer progression in an active surveillance cohort.
    Khondakar, Nabila
    O'Connor, Luke P.
    Williams, Cheyenne
    Daneshvar, Michael
    Egan, Jillian
    Yerram, Nitin
    Webster, Brad
    Merino, Maria
    Choyke, Peter L.
    Wood, Bradford
    Turkbey, Baris
    Pinto, Peter A.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [27] TIMING OF THE CONFIRMATORY BIOPSY IN PROSTATE CANCER ACTIVE SURVEILLANCE: ANALYSIS OF THE CANARY PROSTATE CANCER ACTIVE SURVEILLANCE STUDY (PASS)
    Macleod, Liam C.
    Ellis, William J.
    Newcomb, Lisa F.
    Zheng, Yingye
    Brooks, James D.
    Carroll, Peter R.
    Gleave, Martin E.
    Lance, Raymond S.
    Nelson, Peter S.
    Thompson, Ian M.
    Wagner, Andrew A.
    Wei, John T.
    Yang, Hui-Yu
    Lin, Daniel W.
    JOURNAL OF UROLOGY, 2015, 193 (04): : E755 - E755
  • [28] Predictive models and risk of biopsy progression in active surveillance patients
    Iremashvili, Viacheslav
    Manoharan, Murugesan
    Kava, Bruce R.
    Parekh, Dipen J.
    Punnen, Sanoj
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (02) : 37.e1 - 37.e8
  • [29] VALIDATION OF A RISK CALCULATOR PREDICTING BIOPSY OUTCOME IN PROSTATE CANCER TREATED WITH ACTIVE SURVEILLANCE
    Nieboer, Daan
    Roobol, Monique J.
    Steyerberg, Ewout W.
    Bangma, Chris H.
    JOURNAL OF UROLOGY, 2016, 195 (04): : E229 - E230
  • [30] Tumor Volume on Biopsy of Low Risk Prostate Cancer Managed with Active Surveillance REPLY
    不详
    JOURNAL OF UROLOGY, 2018, 199 (04): : 960 - 960
12345